Drawing for ATRECA

USPTO serial 85275010

ATRECA

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
Examiner
COWARD, JEFFERY
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ATRECA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

R. Gwen Peterson

R. Gwen Peterson Kilpatrick Townsend & Stockton LLPTwo Embarcadero Center, 8th FloorSan Francisco, CA 94111-3834UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Diagnostic preparations and diagnostic kits comprised of buffers and reagents for clinical, medical laboratory, or research use, for predicting the response of patients to therapeutics; biological tissue for research and scientific diagnosis use; antibodies for research and scientific diagnosis use; combinations of biological tissue for research and scientific diagnosis use; combinations of antibodies for research and scientific diagnosis use; kits containing buffers and chemical reagents for use in molecular biology research applicationsACTIVE
005Diagnostic preparations and diagnostic kits comprised of buffers and reagents for medical use, for predicting the response of patients to therapeutics; biologics for medical use, namely, biological preparation for the treatment of infectious disease; biologics for medical use, namely, biological preparation for the treatment of cancer; biologics for medical use, namely, biological preparation for the treatment of autoimmune disease; biologics for medical use, namely, biological preparation for the treatment of cardiovascular disease; biologics for medical use, namely, biological preparation for the treatment of animal health; biologics, namely, biological tissue for medical diagnosis; biologics, namely, antibodies for medical diagnosis; biologics, namely, vaccines for medical diagnosis, research and scientific diagnosis; combinations of biologics for medical use, namely, biological preparation for the treatment of infectious disease; combinations of biologics for medical use, namely, biological preparation for the treatment of cancer; combinations of biologics for medical use, namely, biological preparation for the treatment of autoimmune disease; combinations of biologics for medical use, namely, biological preparation for the treatment of cardiovascular disease; combinations of biologics for medical use, namely, biological preparation for the treatment of animal health; combinations of biologics, namely, biological tissue, antibodies, and vaccines, for medical diagnosisACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jan 11, 2016MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 11, 2016ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 3, 2015CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 3, 2015COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
May 9, 2015EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 8, 2015EX5GSOU EXTENSION 5 GRANTED
Apr 29, 2015EXT5SOU EXTENSION 5 FILED
Apr 29, 2015EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 13, 2014EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 12, 2014EX4GSOU EXTENSION 4 GRANTED
Dec 4, 2014EXT4SOU EXTENSION 4 FILED
Dec 4, 2014EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 22, 2014ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 22, 2014REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 12, 2014EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 11, 2014EX3GSOU EXTENSION 3 GRANTED
Jun 10, 2014EXT3SOU EXTENSION 3 FILED
Jun 10, 2014EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 23, 2014EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 22, 2014EX2GSOU EXTENSION 2 GRANTED
Jan 15, 2014AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 13, 2014AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 21, 2013EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 20, 2013EXT2SOU EXTENSION 2 FILED
May 17, 2013EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 15, 2013EX1GSOU EXTENSION 1 GRANTED
May 15, 2013EXT1SOU EXTENSION 1 FILED
May 15, 2013EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 11, 2012NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 16, 2012NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 16, 2012PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 26, 2012NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 7, 2012PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 7, 2012ALIEASSIGNED TO LIE
Aug 27, 2012CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Aug 27, 2012XAECEXAMINER'S AMENDMENT ENTERED
Aug 27, 2012GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 27, 2012GNEAEXAMINERS AMENDMENT E-MAILED
Aug 27, 2012CNEAEXAMINERS AMENDMENT -WRITTEN
Jul 26, 2012TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Jul 26, 2012CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 26, 2012ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED
Jan 27, 2012GNFNNOTIFICATION OF FINAL REFUSAL EMAILED
Jan 27, 2012GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 27, 2012CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 22, 2011TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Dec 21, 2011CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 21, 2011TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 28, 2011GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Jun 28, 2011GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Jun 28, 2011CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Jun 20, 2011DOCKASSIGNED TO EXAMINER
Mar 28, 2011NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 26, 2011NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance